Therapeutic Area market research reports by DelveInsight

• Glaucoma Market Insight, Epidemiology And Market Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Glaucoma Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Corneal Edema market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of Corneal Edema in the US is expected to increase, driven by the launch of emerging therapie ... Read More

• Dyspepsia- Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Dyspepsia- Pipeline Insight, 2024 DelveInsight’s, “Dyspepsia- Pipeline Insight, 2024” report provides comprehensive insights about 2+ companies and 2+ pipeline drugs in Dyspepsia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also cove ... Read More

• Glaucoma - Epidemiology Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Glaucoma - Epidemiology Forecast - 2034 Key Highlights DelveInsight's analysts project that in the 7MM, around 42% of the total prevalent cases of Glaucoma are diagnosed, owing to factors such as aging populations and enhanced diagnostic techniques facilitating early detection. Approximately 7 milli ... Read More

• Advanced Renal Cell Carcinoma- Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Advanced Renal Cell Carcinoma- Pipeline Insight, 2024 DelveInsight’s, “Advanced Renal Cell Carcinoma- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape. It covers the pipeline drug profiles, i ... Read More

• Anorexia Nervosa - Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anorexia Nervosa - Pipeline Insight, 2024 DelveInsight’s, “Anorexia Nervosa - Pipeline Insight, 2024” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Anorexia Nervosa pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stag ... Read More

• Anti-Depressant Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 4,250

  Anti-Depressant Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Anti-Depressant Drugs Market By Drug Type (Selective Serotonin Reuptake Inhibitors (SSRI), Selective-Norepinephrine Reuptake Inhibitors (SNRI), Tricyclic Antidepressants (TCA), Monoamine Oxidase Inhibit ... Read More

• Acute Respiratory Distress Syndrome- Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Acute Respiratory Distress Syndrome- Pipeline Insight, 2024 DelveInsight’s, “Acute Respiratory Distress Syndrome- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline landscape. It covers the pipelin ... Read More

• Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024 DelveInsight’s, “Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Non-Small-Cell Lung cancer (NSCLC) pipeline landscape. It covers the pipel ... Read More

• Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of hemophilia A was the largest in the US among the 7MM, accounting for approximately USD 5,000 million, which is further expected to increase by 2034. In September 2023, concizumab wa ... Read More

• Traumatic Brain Injury - Market Insight, Epidemiology And Market Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Traumatic Brain Injury - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Idiopathic Membranous Nephropathy (IMN) is a significant type of glomerular disease characterized by the presence of large amounts of protein in the urine (nephrotic syndrome) and is primarily an autoimmu ... Read More

• Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Dry AMD has the potential to progress to geographic atrophy, a stage characterized by irreversible vision loss caused by the depletion of crucial retinal components such as retinal pigment epithelium (R ... Read More

• Schizophrenia- Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Schizophrenia- Pipeline Insight, 2024 DelveInsight’s, “Schizophrenia- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Schizophrenia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

• Acute Kidney Injury- Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Kidney Injury- Pipeline Insight, 2024 DelveInsight’s, “Acute Kidney Injury- Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Acute Kidney Injury pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclini ... Read More

• Helicobacter Pylori Infection - Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Helicobacter Pylori Infection - Pipeline Insight, 2024 DelveInsight’s, “Helicobacter Pylori Infection - Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Helicobacter Pylori Infection pipeline landscape. It covers the pipeline drug profiles, ... Read More

• Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2024 DelveInsight’s, “Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Dry Age-related Macular Degeneration (Dry-AMD) pipeline ... Read More

• Myopia - Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Myopia - Pipeline Insight, 2024 DelveInsight’s, “Myopia - Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Myopia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers th ... Read More

• HER2 Negative Breast Cancer- Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  HER2 Negative Breast Cancer- Pipeline Insight, 2024 DelveInsight’s, “HER2 Negative Breast Cancer- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2 Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles, includi ... Read More

• Epidermolysis Bullosa - Epidemiology Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Epidermolysis Bullosa - Epidemiology Forecast - 2034 Key Highlights Epidermolysis Bullosa is slightly more prevalent in males than females, with approximately 14,000 cases reported in the US in 2023. In 2023, the majority of type-specific cases were attributed to Epidermolysis Bullosa Simplex. Dystr ... Read More

• CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 7,500

  CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights In 2023, the market size of epidermolysis bullosa was highest in the US among the 7MM, accounting for approximately USD 1,300 million, which is further expected to increase by ... Read More

• Retinal Vein Occlusion - Market Insight, Epidemiology And Market Forecast - 2034

  Jan 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Retinal Vein Occlusion - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The prevalence of retinal vein occlusion has been increasing due to the increase in the geriatric population and the surge in awareness about eye disorders. With the growing geriatric population, the dise ... Read More

• Pulmonary Arterial Hypertension Market Insight, Epidemiology And Market Forecast - 2034

  Jan 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Pulmonary Arterial Hypertension Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of myelofibrosis was highest in the US among the 7MM, accounting for approximately USD 1,400 million, which is further expected to increase by 2034. In the 7MM, JAKAFI/JAKA ... Read More

• Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology And Market Forecast - 2034

  Jan 01, 2024  |  Published by: DelveInsight  |  USD 7,500

  Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In the 7MM, the United States accounted for the largest market size in 2023, with approximately USD 6,500 million. The disease is reported to occur in 20–50% of those living with diabetes and is t ... Read More

• Short Bowel Syndrome Market Insight, Epidemiology And Market Forecast - 2034

  Jan 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Short Bowel Syndrome Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size of short bowel syndrome in the 7MM was ~USD 2,300 million in 2023, which is expected to grow during the forecast period 2024–2034. Due to diminished absorptive capacity from the reduced ... Read More

• Cough in Idiopathic Pulmonary Fibrosis (IPF) - Epidemiology Forecast– 2034

  Jan 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Cough in Idiopathic Pulmonary Fibrosis (IPF) - Epidemiology Forecast– 2034 Key Highlights According to DelveInsight’s estimates in 2022, the total diagnosed prevalent cases of Cough in IPF in the 7MM were nearly 148,000 in 2022, which is expected to increase by 2034 due to improved awareness, aging ... Read More

• Cough in Idiopathic pulmonary fibrosis (IPF) – Market Insights, Epidemiology, and Market Forecast – 2034

  Jan 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Cough in Idiopathic pulmonary fibrosis (IPF) – Market Insights, Epidemiology, and Market Forecast – 2034 Key Highlights The Cough in IPF market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of Cough in IPF in the 7MM is expected to increase, dr ... Read More

< prev 18 19 20 21 22 23 24 25 26 27 next >